Table 2 Expression levels of 12 plasma miRNAs between early-stage NSCLC patients and healthy controls
From: Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer
miRNAs | Expression | NSCLC/Healthy | P value |
|---|---|---|---|
miR-20a | ↑ | 12.34 × 0.78 | 1.45 × 10 -3 |
miR-223 | ↑ | 5.67 × 0.56 | 2.34 × 10 -3 |
miR-21 | ↑ | 5.09 × 0.53 | 3.31 × 10 -5 |
miR-155 | ↑ | 4.34 × 0.3 | 1.67 × 10 -3 |
miR-221 | ↑ | 1.32 × 0.29 | 0.063 |
miR-25 | ↑ | 1.26 × 0.28 | 0.082 |
miR-182 | ↑ | 1.03 × 0.27 | 0.723 |
miR-30d | ↑ | 0.98 × 0.25 | 0.459 |
miR-126 | ↑ | 0.87 × 0.24 | 0.239 |
miR-320 | ↑ | 1.84 × 0.77 | 0.071 |
miR-210 | ↑ | 0.57 × 0.15 | 0.563 |
miR-145 | ↑ | 20.24 × 0.83 | 3.56 × 10 -4 |